Improvement of Portal Hypertension and Hepatic Blood Flow in Liver Cirrhosis by Estrogen
Improvement of Portal Hypertension and Hepatic Blood Flow in Liver Cirrhosis by Estrogen
批准号:
16590649
负责人:
SAKAMOTO Masaharu
金额:
$1.6万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2006
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Background : In this study, we investigated the effects of estrogen on nitric oxide synthase activity and nitric oxide production using the cirrhotic rat liver.Material and Methods : Cirrhosis was induced by dimethylnitrosamine. Estradiol valerate was subcutaneously injected 2 times at week 4 after dimethylnitrosamine treatment. Furthermore, subcutaneous injection of an estrogen receptor antagonist, ICI-182.780, was performed 2 days before administration of estradiol valerate. Portal pressure and hepatic blood flow were measured. Nitric oxide synthase activity was assessed by L-citrulline generation. Sinusoidal endothelial cells were isolated from the cirrhotic rat liver and cultured. The cells were incubated with estradiol and/or ICI-182.780 for 24 hours. Images for nitric oxide in sinusoidal endothelial cells were obtained using diaminofluorescein-2 diacetate.Results : Cirrhotic rats treated with estradiol valerate showed a significant decrease in portal pressure and a significant increase in hepatic blood flow compared to those of control cirrhosis rats. However, in cirrhotic rats treated with ICI-182.780, the reduction of portal pressure and elevation of hepatic blood flow were completely inhibited. In cirrhotic rats treated with estradiol valerate, nitric oxide synthase activity was increased compared to that in control cirrhotic rats. The fluorescent level of intracellular nitric oxide in estradiol-stimulated cultured sinusoidal endothelial cells was higher than that in non-treated sinusoidal endothelial cells.Conclusions : The present study indicated that estrogen plays an important role in the enhancement of nitric oxide production in sinusoidal endothelial cells of cirrhotic liver and reduces the portal pressure in cirrhotic rats.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1111/j.1365-2362.2005.01476.x
发表时间:
2005-03
期刊:
European Journal of Clinical Investigation
影响因子:
5.5
作者:
[M. Sakamoto;T. Ueno;T. Nakamura;R. Sakata;O. Hasimoto;T. Torimura;M. Sata]
通讯作者:
M. Sakamoto;T. Ueno;T. Nakamura;R. Sakata;O. Hasimoto;T. Torimura;M. Sata
類洞壁細胞の機能と生活習慣
正弦壁细胞的功能和生活方式
DOI:
--
发表时间:
2005
期刊:
肝胆膵 51・11
影响因子:
--
作者:
[上野隆登, 他]
通讯作者:
他
Improvement of portal hypertension and hepatic blood flow in cirrhotic rats by estrogen
雌激素对肝硬化大鼠门脉高压和肝血流的改善作用
DOI:
--
发表时间:
2005
期刊:
Eur J Clin Invest. 35
影响因子:
--
作者:
[Shimosawa T, Takano K, Ando K, Fujita T., Aizawa Y et al., Masaharu Sakamoto]
通讯作者:
Masaharu Sakamoto
肝類洞壁細胞からみた門脈圧亢進の機序
从肝窦细胞角度探讨门脉高压的机制
DOI:
--
发表时间:
2005
期刊:
肝臓フォーラム 16
影响因子:
--
作者:
[Kawai J, Ando K, Tojo A, Shimosawa T, Takahashi K, Onozato M, Yamasaki M, Ogita T, Nakaoka T, Fujita T., 坂本 雅晴]
通讯作者:
坂本 雅晴
肝硬変における肝内血管抵抗の成因
肝硬化肝内血管阻力的原因
DOI:
--
发表时间:
2004
期刊:
肝胆膵 49
影响因子:
--
作者:
[Suzuki J, Ito H, Gotoh R, Morishita R, Egashira K, Isobe M., 上野 隆登]
通讯作者:
上野 隆登
海外基金